Armodafinil significantly increases dopamine levels in the brain by blocking dopamine transporters. In certain regions of the brain, including the striatum and hypothalamus, Armodafinil 150 has been shown to increase dopamine levels extracellularly. Controlling motivation, wakefulness, and attentiveness are associated with these regions. The effectiveness of modafinil to increase alertness is thought to be influenced by dopamine-related actions.
Armodafinil is a prescription smart pill that is a member of the eugeroic pharmacological class. Eugeroics are typically prescribed to treat diseases including narcolepsy, sleep apnea, and shift work sleep disorder while also promoting wakefulness.